Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Oncoimmunology|December 8, 2018
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patientsBelinda Palermo, Ornella Franzese, Cosmo Di Donna, et al.
Dermatology (Basel, Switzerland)|June 6, 2013
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanomaVanna Chiarion-Sileni, Michele Guida, Antonella Romanini, et al.
Current Medical Research and Opinion|July 27, 2007
A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancerAlain J Gelibter, Teresa Gamucci, Camillo F Pollera, et al.
Cancers|July 29, 2025
Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary StudyAntonino Guerrisi, Maria Teresa Maccallini, Italia Falcone, et al.
Frontiers in Oncology|June 5, 2023
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alphaFederica Moschella, Carla Buccione, Irene Ruspantini, et al.
Cancer Research|September 9, 2010
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patientsBelinda Palermo, Duilia Del Bello, Alessandra Sottini, et al.
Oncogenesis|February 24, 2018
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcomaMarta Di Martile, Marianna Desideri, Maria Grazia Tupone, et al.
Frontiers in Oncology|October 25, 2021
Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics ApproachAntonino Guerrisi, Michelangelo Russillo, Emiliano Loi, et al.
International Journal of Molecular Sciences|September 23, 2022
Malignant Transformation of Giant Cell Tumour of Bone: A Review of Literature and the Experience of a Referral CentreSabrina Vari, Federica Riva, Concetta Elisa Onesti, et al.
Tumori|February 18, 2015
Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)Stefano Ferrari, Cristina Meazza, Emanuela Palmerini, et al.
Pageof 12